Verge Genomics raises $32 mln from DFJ, ALS Investment Fund, Agent Capital, others

Verge Genomics said it raised $32 million of Series A capital in a round led by DFJ and joined by new investors WuXi AppTec’s Corporate Venture Fund, ALS Investment Fund, Agent Capital, and OS Fund.

16 July 2018•4 mins read
Feature image
LinkedInXEmail
LinkedInXEmail